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Executive Summary 
The Prostate Cancer Screening Program at the Markey Cancer Center co-sponsors prostate cancer 
screenings with the Prostate Cancer Education Council. All participation, including African-American 
attendance, has decreased 38% from years 2006 to 2008 and program managers are seeking insight to 
improve program participation by acquiring knowledge of behavioral and medical characteristics that 
may influence screening attendance.  Because of the higher incidence of prostate cancer in African-
American men (ACS, 2008), a specific program goal is also to increase screening attendance for this 
minority population.   
Problem Statement 
 
 
Questions that assess participant behavior, personal, and family medical history are analyzed to 
determine specific relevant variables that may influence participation.  A general description of the data 
and participation rates, for new and returning participants, is presented. Variable analysis will be 
conducted for certain behavioral factors and grouped variable analyses will be conducted for urinary, 
sexual and testosterone health symptoms.  Relevant variables with predict returning participant 
behaviors. 
Research Strategy 
 
 
Personal and family health histories play an important role in participation.  Men who consider 
themselves high risk are more likely to smoke, and returning participant models found that men with 
these variables are more likely to return.  Returning African-American behavior is largely unknown 
although a small portion of men are suffering from testosterone health symptoms. Sexual health 
symptoms play an important role in the overall attendance of African-American men. Urinary health 
symptoms do not play an important role in the attendance of program participants.  This might be 
unfortunate, considering that urinary symptoms are more relevant to prostate cancer than sexual health 
symptoms.  There are no statistically significant differences related to race, but this is a policy problem, 
given that African-American’s are more likely to have prostate cancer. 
Major Findings 
Most participants report receiving information about the program via:  newspaper, friends and family, 
and by radio and television.  Program managers can use the findings about behavioral and medical 
factors that affect participation to develop targeted marketing strategies.  Marketing avenues that are 
effective and have not been explored are places of work and wives or significant others.   
 
It is recommended that program managers should focus marketing efforts on men with sexual and 
testosterone health symptoms, those who believe they are at high risk for prostate cancer to encourage 
retention.  A special marketing effort towards African-Americans is essential in realizing program goals.  
Program managers should strategize marketing efforts via newspaper, radio, television, and the 
internet.  Different motives underlie decisions to seek or return for screening including:  high risk, health 
consciousness, and pressure from a wife, and marketing initiatives could target all of these.  Greater 
success in attracting returning African-Americans would be relevant and is not, at present, occurring.   
Recommendations 
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I. Background and Relevant Facts 
A.  Program Background 
 This research paper reports findings from a survey given to prostate 
screening attendees at the Markey Cancer Center (Markey).  Data from 2006-2008 
were analyzed to identify factors, relationships, and trends in the behavior of both 
returning and new participants in the prostate cancer screening program.  The goal 
of the research is to develop information that is useful to program managers, 
administrators, and grant givers in an effort to continue the program and increase 
attendance.  
 Organizations, such as the Prostate Cancer Education Council (PCEC) co-
sponsor prostate cancer screenings to encourage early detection methods.  Prostate 
cancer screenings at the Markey Cancer Center are held in conjunction with Prostate 
Cancer Awareness Week (PCAW), a national program coordinated by the PCEC.  The 
PCEC currently has more than 600 research screening sites, and since its inception in 
1989, has screened more than 3,000,000 men (PCEC, 2009).  
  PCAW is usually held in September, and Markey operates two (2) additional 
screening programs annually in April and December.  Program participation is open 
for all Kentucky residents.  The Kentucky Cancer Program, in conjunction with the 
University of Kentucky, runs the program and pays for nearly half of the program 
expenses with grant monies received from Toyota Motor Manufacturing.  The grant 
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is currently managed by the Markey Cancer Foundation.  To keep expenses low, the 
benefit of participating in the PCEC co-sponsored screening is that of discounted lab 
costs for Prostate Specific Antigen exams (PSA).  
 Currently, program managers advertise the program on local radio and 
televisions stations, in community newspapers, and on the UK HealthCare and PCEC 
websites.  Analyses presented here will help target marketing efforts to improve 
program participation, specifically for African-American men.  Under the direct 
supervision of the PCEC, Markey meets HIPPA and Internal Review Board (IRB) 
compliance for the study.   However, targeting men for the program continues to 
need improvement.   
 In the state of Kentucky various initiatives are in place to encourage early 
detection and education about prostate cancer health.   There are four cancer 
centers that participate in free or reduced cost prostate cancer screening programs:   
the University of Kentucky’s Markey Cancer Center (Markey), the Jennie Stuart 
Medical Center in Hopkinsville, the Leonard Lawson Cancer Center located in 
Pikeville, and the James Graham Brown Cancer Center in Louisville.  Geographically, 
Markey is the only Central Kentucky participating partner with the PCEC program. 
 Currently, three out of four screening sites in Kentucky participate in the 
PCEC co-sponsored longitudinal study; however, data are only available from 
Markey.  A longitudinal study is a research study that extends for several years and is 
often aimed at developing conclusive evidence for policy makers.  The program’s 
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mission is to screen and educate Kentucky’s men about the warning signs, health 
hazards, and treatment options of prostate cancer.  There are 5 initiatives for the 
2009 grant: 
1. Provide education and instill awareness across the entire regional service 
area concerning prostate cancer, overall health and wellness, and the 
possibility and importance of early prostate cancer detection. 
2. Provide specific opportunities for prostate cancer screening at no financial 
cost to participants. 
3. Increase minority participation. 
4. Maintain quality of current program. 
5. Increase early detection rates, cure and quality of life. 
 Grant objectives are to improve attendance year after year, specifically for 
minority populations.   Funding for cancer research, education, and screening has 
long been promoted by private and public donation.  The most recent statistics by 
the PCEC estimate that that prostate cancer programs are underfunded and 
currently for every $100 donated to breast cancer only $1 is given to prostate cancer 
health and research programs.  However Markey has been successful in seeking 
funding.   
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B.  Relevant Facts 
 Prostate cancer is the second leading cause of cancer death after lung cancer 
for men and is the second most common cancer after skin cancer (PCEC, 2008).  
Several years ago statistics estimated that prostate cancer would strike one in 
eleven males during their lifetime (PCEC, 2008).  Today, it’s one in six, and the 
American Cancer Society (ACS) predicts that 1 in 35 men or 28,660 will die of this 
disease in 2008 (ACS, 2009).  Screening already plays a key role in the management 
of cervical and breast cancer, and is likely to become more important in the control 
of colorectal, prostate and lung cancer (ACS, 2009).  
 Prostate cancer isn’t just a burden emotionally or physically—it’s a burden 
financially.  CANCER, a peer-reviewed journal for the American Cancer Society 
published a study that estimates the cumulative cost for prostate cancer at $42,570 
for five years, (Wilson, 2006) and individual out-of-pocket cost for other types of 
cancer survivors on average at $8,900 (Harrington, 2009).  Based on US Medicare 
data, the cost per life year saved by the two most popular prostate cancer screening 
mechanisms, the PSA and the Digital Rectal Exam (DRE),  compared with no 
screening was $12,502-$15,213 for men aged 65, $27,075 in men aged 70, and 
$41,672-$55,681 in men aged 75 (Barry, 1995).   
 Economic issues play an important role in medical decision-making, and are 
just as important in prostate cancer screenings (Imamura, 2008).  The importance of 
the program is not only justified because of its ability to save lives but also the 
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economic and societal impact prostate screening can have on the community.   
Because identifying prostate cancer early provides men the best chance of survival 
and financial freedom, early detection represents one of the most promising 
approaches in reducing the growing cancer burden (Etzioni, 2003).   
 “The promise for early detection is that it will identify cancer while still 
localized and curable, preventing not only mortality, but reducing morbidity and 
costs.” (Etzioni, 2003).  More than 2 million men in the United States who have had 
prostate cancer at some point are still alive today (ACS, 2009).  According to the ACS, 
the death rate for prostate cancer has decreased, and if detected early, prostate 
cancer is considered highly curable.  In fact, ACS also reports that the 5-year survival 
rate of men with prostate cancer detected in the earliest stages is 100% (PCEC, 
2008). Screening serves as an early detection tool as 79% of all prostate cancers are 
discovered in their local and regional stages have a 5-year survival rate of 100%, and 
according to more specific data, 67% of men diagnosed with prostate cancer survive 
10 years and 52% survive for 15 years (ACS, 2009). 
 Although prostate cancer mortality rates declined 4.4% among men 
nationally from years 2001 to 2005 (Rabin, 2008), prostate cancer incidence among 
African-American men remains more than twice as high among white men (ACS, 
2008).  Markey realizes the need to encourage the screening of African-American 
men, and specific program initiatives are being put in place to increase all minority 
screenings in 2009 (MCF, 2009).  African-Americans are more likely to be diagnosed 
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with advanced stage diseases for breast, cervical, colorectal, lung, prostate, and 
ovarian cancers and men who have a longer time between doctor’s visits have 
poorer survival rates (Wade, 2008) and substantial long-term prostate-related 
expenditures (Medical News Today, 2006).  
 Research shows that prostate cancer is disproportionately prevalent among 
African-American men.  Average incidence of prostate cancer is 60% higher in 
African-American men when compared to white men, and African-American’s have 
the highest mortality rate of any ethnic or racial group. (Crowford, 2003).  
Additionally, African-American men who have a family history of prostate cancer 
have a 75-80% higher risk of developing prostate cancer (Catalona, 2002). In fact, 
over twice as many African-American men are diagnosed with prostate cancer, and 
more than twice as many die from the disease (PCEC, 2009). 
 The relationship between prostate cancer incidence and African-American 
men proves to be important to prostate cancer screening programs, as there is also 
discussion that the financial burden of prostate cancer is more significant for 
African-Americans as they are more often lower on the socio-economic ladder and 
are more likely to be uninsured or underinsured.  A lack of health insurance serves 
as an influence in screening decisions (Cancer Council, 2009), and the free prostate 
cancer screening program may be a solution for prostate cancer screenings for 
lower-income men. 
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 According to the Kaiser Foundation, the uninsured rate of non-elderly 
African-American’s is 21% compared with 17% for the population as a whole (Wade, 
2008).  Currently, Markey’s prostate screening program has remained flat in 
targeting African-American men, as from years 2006 to 2008 screenings recruited 
nearly 7.3% of African-Americans, while according to the 2000 census the state of 
Kentucky’s African-American population is 7.7%. There is no statistically significant 
difference between population proportions and screening proportions, but the 
higher incidence of prostate cancer in African-Americans implies that the screening 
rate should be higher in this group.  The program is currently seeing a decrease of 
almost 38% in attendance of all men, and program managers are looking for insights 
into how to improve participation.   
C.  General Data Description 
 The program had a total of 1,019 participants comprised of 945 non African-
American participants and 74 African-American participants from years 2006 to 
2008.  
 Chart 1:  Total Participation, New versus Returning 2006-2008 
  2006 2007 2008 Total 
  Returning New Returning  New Returning  New  
All Participants 258 136 220 158 178 69 1,019 
African-American Participants 20 10 14 10 8 12 74 
        
Total Participation 394 378 247  
Return %  65% 58% 73%   
New %  35% 42% 27%   
African-American Participation 30 24 20  
Return % 66% 58% 40%   
New % 33% 41% 60%   
        *Source:  PCEC 2008. 
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   Total participation has fallen year over year from 2006 to 2008.  Total 
participation was at 394 participants in 2006, 378 in 2007, and 247 in 2008.  Total 
program participation has decreased 38% from years 2006-2008.  Of those 
participants, the percentage of returning participants from 2006 to 2008 was 65% in 
2006, 58% in 2007 and 73% in 2008.  Although 2008 had a record returning 
participant year of nearly 73%, total new participation dropped nearly 30% from 
2006 to 2008. 
 The specific data for African-American men followed a similar pattern. There 
was a 44% drop in total participation from 30 in 2006 to 20 in 2008.  Although the 
number of new participants grew by nearly 45%, there was a decrease in returning 
African-American participants by 65%. 
 The most common age group for participation was 61-70 for all participants 
(Chart 1) and between ages of 51-60 for African-American men.  The majority of 
total participation among men older than 51 years of age, but African-American 
participants are generally younger than the majority of other participants. 
Chart 1:  Participant’s Age 2006-2008  
 
     *Source PCEC 2009 
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 The most common way that participants learned about the program, as 3-
year averages report (Chart 2) was by two popular methods:  friends and family and 
the newspaper. 
Chart 2:  How did you hear about the screening, all participants 2006-2008  
 
      *Source PCEC 2009 
 
There was little difference in the results between new and returning participants, 
although the source of receiving word of the program via work plays an important 
role for returning participants, and radio and television play an important role in 
drawing new participants (Chart 3) and specifically African-American men (Chart 4).   
Chart 3:  How did you hear about the screening,  
returning vs. new participants 2006-2008 
 
  *Work variable was tracked in 2007 & 2008 only   *Source PCEC 2009 
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Chart 4:  How did you hear about the screening, 
African-American Participants 2006-2008 
 
  *Work variable tracked only in 2006 & 2007   *Source:  PCEC 2009 
 
It is important to note that the work variable was only tracked in 2007 and 2008, and 
it can be reasonably predicted that it would have been important in 2006.  The 
“other” category appears to be a strong third, but due to a lack of specifics, that 
method of program marketing was eliminated from this analysis.   
II.  Research Design 
 Panel data or data that follows the participant through a series of methodical 
questions over multiple time periods helped me examine medical and behavioral 
factors that may encourage program attendance.  Behavioral and medical factors 
will include attendance rationale, health implications, family cancer incidence, and 
the feeling of being at high risk for prostate cancer.  Medical factors include whether 
men are currently suffering from urinary, sexual and testosterone health symptoms 
and will also record if they are obese (tracked by participant’s BMI).  Participant 
models was developed using a statistical regression from relevant variables.   
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 Data will be analyzed for behavioral and medical differences in returning 
versus new participation, and for African-American men specifically.  For research 
clarification, a new participant in 2008 did not participate in 2007 or 2006, a new 
participant in 2007 did not participate in 2006, and a new participant in 2006 did not 
participate in 2005.  Data collected from PCEC patient-doctor questionnaires will be 
statistically analyzed to estimate medical and behavioral characteristics in an 
attempt to uncover attendance rational and to give managers better participant 
understanding.  Theses medical and behavioral factors will then predict future 
participation models for new and returning program attendees.    
 Specific assessments will be made for behavioral questions, while grouped 
medical factor analyses will be made for urinary, sexual and testosterone symptom 
evaluations.    Specific assessments will address each factor for significance. Grouped 
assessments will group responses to track individuals who are feeling one or more 
symptoms on an index of suffering from urinary, testosterone or sexual health 
problems.  Analyses are split between returning and new participants to analyze 
differences.  The following hypothesis and research questions will be addressed: 
A.  Hypothesis: 
There are several medical and behavioral factors that contribute to participation in 
the prostate cancer screening program including the feeling of being at high risk and 
being health conscious.  Participants with a family history of prostate cancer and 
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personal health status as related to urinary, sexual, and testosterone health 
symptoms are more likely to attend the program.  
Research Questions: 
What behavioral factors influence the decision for men to attend a 
screening? 
What medical factors influence the decision for men to attend a screening; 
including family, personal medical history and current urinary, sexual and 
testosterone health issues? 
What do participants feel categorizes them as “high risk”?  Does smoking 
influence this assumption? 
Are there specific behavioral and medical factors for African-American men? 
What factors affect participation? 
What factors can program managers use to improve and expand the 
program? 
Assessments will be made in the following ways: 
1.  Behavioral characteristics- will specifically assess participant behavior and 
lifestyle indicators for attending the screening, current personal health 
status, and family medical history.  The analysis will use regression to 
estimate the effect of relevant factors of new versus returning participants.  
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These are discrete or categorical variables. Percentages will describe the 
relevance of personal and family health history, and incidence of smoking 
regarding those who identify themselves as high-risk candidates.  A factor 
analysis will also be completed to estimate reason attended. 
2. BMI test- will specifically assess participants BMI as a lifestyle indicator to 
predict the difference between new and returning program participants.  
3.  Urinary Symptoms Evaluation- will be grouped to assess if the participant is 
suffering from urinary symptoms as a possible reason of attending the 
screening.  A participant will be characterized as “suffering from symptoms” 
if a problem occurs at least half or more than half of the time, if they are 
urinating more than three times a night, and if they are dissatisfied with their 
urinary condition.   Using factor analyses to summarize the indicators, the 
analysis estimates if there is a relationship between suffering from urinary 
symptoms and attending the screening.   
4.  Sexual Health Inventory- will be grouped to assess if the participant is 
suffering from sexual health issues as a possible reason for attending the 
screening.  A participant will be characterized as “suffering from symptoms” 
if a symptom occurs at least half or more than half of the time, if they have 
low confidence in an erection, have difficulty or if they do not attempt 
intercourse.  Factor analyses will summarize the conditions. 
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5. Testosterone Test- survey questions will be grouped to assess if the 
participant is suffering from testosterone health issues as a possible reason 
of attending the screening.  A participant will be characterized as “suffering 
from symptoms” if a response of “yes” is marked for any or all of the 
questions.  Factor analyses will summarize the conditions.   
6.   Participant Models- will analyze variables found in the above tests in a 
regression to predict future new and returning participant behavior.
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Responses to the  following questionnaire are used in analysis: 
1. GENERAL DATA DESCRIPTION 
Age 
What race/ethnicity best describes you? 
Years participated in PCAW? 
How did you hear about the free screening during Prostate Cancer Awareness Week? 
 
2. BEHAVIORAL INVENTORY 
Do you smoke or have you been a smoker? 
What health conditions or procedures do you/have you had? 
What is your family health history? 
Why are you attending this screening program? 
 
3. MEDICAL INVENTORY- BMI CALCULATION 
 
4. MEDICAL INVENTORY- URINARY SYMPTOMS EVALUATION 
How long after you had a sensation of not emptying your bladder completely after you finish urinating?  
How often have you had to urinate again less than two hours after you finish urinating? 
How often have you found that you stopped and started again several times when you urinate? 
How often have you found it difficult to postpone urination? 
How often have you had a weak urinary stream? 
How often do you push or strain to begin urination? 
If you spent the rest of your life with your urinary condition just the way it is now, how would you feel? 
 
5. MEDICAL INVENTORY- SEXUAL HEALTH INVENTORY 
How do you rate your confidence that you could get and keep an erection? 
When you had erections with sexual stimulation, how often were your erections hard enough for 
penetration (entering your partner)? 
During sexual intercourse, how often were you able to maintain your erection after you had penetrated 
(entered) your partner? 
During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? 
 
6. MEDCIAL INVENTORY- LOW TESTOSTERONE TEST (FY ’08 % ’09 only) 
Do you have a decrease in libido (sex drive)? 
Do you have a lack of energy? 
Do you have a decrease in strength and/or endurance? 
Have you lost height? 
Have you noticed a decreased "enjoyment in life"? 
Are you sad and/or grumpy? 
Are your erections less strong? 
Have you noticed a recent deterioration in your ability to play sports? 
Are you falling asleep after dinner? 
Has there been a recent deterioration in your work performance? 
 
 16 
 
III.  Analysis, Findings and Limitations 
 This research study focuses on assessing participant behavior related to their 
medical history, family health history, and any personal reasons for attending the 
screening.  Analysis and findings will report on the success of current marketing and 
outreach methods, a participant’s behavioral and medical reasons for attending the 
screening, and their BMI as a lifestyle indicator.   
A.  Behavioral Factors: 
  Behavioral factors will address a participant’s lifestyle through variables, such 
as their amount of exercise per week, amount of fat in their diet, smoking, and 
current health problems.  Some of these behaviors are also variables in the 
predictive returning participant models discussed later in the analysis.   As displayed 
in Table 3, most participants have a diet medium in fat (Chart 5), do not smoke 
(Chart 7) and exercise 2-3 times per week (Chart 10).  Interestingly, the incidence of 
participant smoking is nearly 32%, a higher percentage than the current state of 
Kentucky’s average at 28.3% (WebMD, 2009).  
Table 3:  Current Participant Behavior 2006-2008 
Behavior Frequency 
Diet Medium in Fat 74% 
Do Not Smoke 74% 
Exercise 2-3 times per week 42% 
 
 17 
 
 Current African-American behavior and general participant behavior match 
show nearly identical results based on their amount of fat in diets, smoking and 
frequency of exercise although more than 12% of African-American men had a diet 
high in fat nearing over 2 times that of the average in the entire dataset of fat in diet 
at 6% (Chart 6).   
Table 4:  Current African-American Participant Behavior 2006-2008 
Behavior Frequency 
Diet Medium in Fat 72% 
Do Not Smoke 78% 
Exercise 2-3 times per week 42% 
 
 A participant’s personal and family medical history provides insight into the 
rationale behind attendance.  Participants, as a whole, commonly suffer from high 
cholesterol and high blood pressure—two very common health conditions (Medicine 
Net, 2009).  It is important to note that there are several factors that follow with 
relatively high incidence such as: enlarged prostate, prostate infection, erectile 
dysfunction, heart disease, and type 2 diabetes (Chart 11).  Health conditions 
specific to African-Americans follow similarly (Chart 12) with the exception that 
African-American men had a significantly higher rate of diabetes at 20.3% compared 
to the dataset at 7.8%.  Specific health symptoms for urinary, sexual, and 
testosterone problems will be assessed for attendance relevance in the medical 
section below. 
 18 
 
 The last behavioral factor assessed was the reason the men attended the 
screening.  Overwhelmingly, new and returning participants (Chart 15 & 16) 
attended the screening because they wanted to be certain they did not have 
prostate cancer for both all participants and for African-American men specifically.  
The second most popular attendance reason was the factor I am very health 
conscious.  Although the other factors remain somewhat level in relationship to each 
other, African-American men had a large portion of nearly 30% of total attendees 
declare they were at high risk compared with total participation at 11% (Chart 15 & 
16), and mostly they were returning participants.    
 A factor analysis of reasons for attending indicates there may be several 
different motivations and influences for attending.   The strongest factor will have 
the highest numerical weight for each variable in Table 5.  The first (strongest) factor 
is high risk (and family history) without a desire for certainty; this is a well-informed 
group seeking testing.  The second factor is general health consciousness.  The third 
factor is a combination of high risk and desire for certainty, and the fourth is wife’s 
encouragement.   The existence of different factors implies a need for different 
advertising to reach differently motivated men.  The certainty some seek cannot be 
promised, of course, but advertising can target high risk men, health conscious men, 
and wives.   
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Table 5:  Factor Analysis of Reason Attended 2006-2008 
Variable Factor 1 Factor 2 Factor 3 Factor 4 
I think I am at high risk *0.3808 -0.0498 *0.1245 -0.0410 
My wife encouraged me to attend 0.0834 -0.1467 -0.2013 *0.1081 
I want to be certain I don't have prostate 
cancer -0.2802 -0.1573 *0.1265 -0.0083 
I am very health conscious -0.0620 *0.3413 -0.0210 0.0250 
I am interested in men's health -0.1999 -0.0082 0.1067 0.0985 
I have a family history of prostate cancer *0.1880 0.0352 0.1322 0.1357 
 *Strongest variables in each factor 
 
 A particular behavioral assessment will look at those who considered 
themselves high risk and by looking at their family health history we can determine 
what factors they consider to be threatening for prostate cancer incidence.  For 
example, in Chart 13, among total participants it is sensible that men who deemed 
themselves high risk for prostate cancer had a relatively high incidence of prostate 
cancer in their family, and primarily the incidence of prostate cancer in their father.  
The incidence of diabetes in the family was the second most common family health 
history factor in men who believe they are high risk for prostate cancer, a health 
factor that has no proven health correlation with prostate cancer.  (Perhaps the fact 
that diabetes is associated with many other health problems is important here.)  
Finally, although it is a variable for personal health and not family health- the factor 
of participant’s smoking was assessed for those who considered themselves high 
risk.   The addition of a participant smoking variable proved to be a very strong 
factor to men believing they are at high risk for prostate cancer.   However, there is 
no scientific basis for such a belief.  
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 Those African-American men who attended the screening did not have a high 
incidence of family prostate cancer, but instead declared themselves high risk for 
relatively high incidences of family history with diabetes and heart disease and if 
they smoked (Chart 14).  Smoking appears to have strong effect in men who 
consider themselves high risk for prostate cancer for both African-American men 
and also for the entire dataset. 
 There were seven variables that showed statistical difference in behavior 
between returning versus new participants:  These split variables between new and 
returning participants all had a statistically significant mean difference with p-values 
less than .05.  Variables that have higher means show relevance to participants that 
are new or returning.  For example, new participants tend to have diets higher in fat, 
tend to be smokers, have a higher BMI, think they are at high risk for prostate 
cancer, and were encouraged by their wives to attend the screening.   Men who 
have had prostate infections and are interested in men’s health are more likely to be 
returning participants.  
Table 6: Relevant Behavioral and Medical Variables 2006-2008  
Variable P-Value Higher Mean 
Amount of diet in fat 0.003 New 
Smoking 0.049 New 
Prostate Infection 0.025 Returning 
BMI 0.036 New 
I think I am at High Risk for Prostate Cancer 0.006 New 
My Wife Insisted I attend the Screening 0.002 New 
I am Interested in Overall Men’s Health 0.049 Returning 
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These variables indicate there are differences in the behavior between new and 
returning participants and should therefore be placed into “participant model” 
regressions for further differentiation between future new and returning participant 
behavior. 
B.  BMI Test 
 BMI proves to be significantly different between all new and returning 
participants, with a p-value of .036.  In African-American men the variable also 
proves worthy of further investigation between new and returning participants with 
a p-value of .028<.05.  Generally, new participants tend to have a higher BMI than 
returning.  This difference may have implications to participant lifestyle and health.  
BMI may also have a relationship to other health variables assessed in participant 
models.  
Table 7:  BMI Returning versus New Participant Difference 2006-2008 
Variable P-Value Higher Mean 
BMI All Data 0.036 New 
BMI African-American men 0.028 New 
 
C.  Medical Factors 
 A look at a participant’s health regarding urinary, sexual, and testosterone 
symptoms may indicate additional reasons for attendance.  Each of these is 
represented by a factor analysis, which indicates that all measures can be combined 
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into a nearly equally-weighted index.  Only one factor matters at all, unlike the 
analysis of reasons for attendance, above.  A specific t-test was performed for 
urinary, sexual, and testosterone health symptoms and by converting t-test values to 
p-values, we can look for variable relevance for those with p-values that are <.05. 
Table 8:  Health Symptoms New versus Returning Participant Difference 2006-2008  
Variable P-Value All Participants P-Value African-American Men Higher Mean 
Urinary Health Problems 0.469 0.456 Returning 
Sexual Health Problems *0.014 *0.035 New 
Testosterone Factors *0.015 0.064 New 
*Results are relevant 
 We can see that there are two variables that show significance, sexual health 
symptoms and testosterone health symptoms.    The results show that sexual and 
testosterone health symptoms are more relevant to new participants and that men 
with urinary health symptoms are more likely to be a returning participant.   The 
statistical analysis suggests no difference between these two groups on the urinary 
variable.  This is unfortunate, given that urinary health problems are much more 
closely related to prostate cancer detection than the other two factors, sexual 
health and testosterone problems (May Clinic, 2009). 
D.  Returning Participant Models 
 Using some of the relevant variables found in the foregoing analysis, a 
participant model can be estimated for new and returning participants both for the 
all participants and for African-American men specifically.  Relevant medical 
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variables used in the model were urinary, sexual health, and testosterone factors 
and behavioral.  The independent variables are:  age, ethnicity, smoking, BMI, if they 
considered themselves high risk, health conscious, if they were interested in overall 
men’s health, and if their wife encouraged them to attend the screening as shown in 
this regression and the dependent variable is if the participant was returning.  
Table 9:  Predictive Returning Participant Model 
Variable Coefficient T-Test Value P-Value 
I consider myself health conscious -0.168 -3.200 *0.001 
Testosterone Health Symptoms -0.052 -2.280 *0.023 
Sexual Health Symptoms -0.021 -1.120 0.262 
I am interested in overall men’s health -0.018 -0.240 0.808 
My wife encouraged  me to attend -0.008 -0.070 0.941 
Age -0.003 -1.460 0.143 
BMI 0.002 0.700 0.483 
Urinary Health Symptoms 0.030 1.310 0.190 
Smoking 0.078 2.070 *0.039 
I think I am at high risk  0.114 2.560 *0.011 
African-American Participant 0.087 1.110 0.268 
*Negative Values= Unlikely returning 
participant behavior  
              *Positive Values= Likely        
behavior for returning participants 
                                             *Variables show relevance in model    
 Data with negative coefficients signify that the variable is unlikely behavior 
for a returning participant, and variables with positive coefficients are behaviors that 
are likely for returning participants.  Further analysis will consider whether these 
variables did have an impact by assessing their p-values.   Men who consider 
themselves health conscious and have testosterone health symptoms are less likely 
to return and men who thought they were high risk or smoked were more likely to 
return.  Behavior variables that had proven significance in a participant not 
returning was if they considered themselves health conscious (p-value of .001) and if 
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they had testosterone health symptoms (p-value of .023).  Variables that proved 
significant for returning participants were if they thought they were at high risk (p-
value of .039) and if they smoked (p-value of .011). 
 This model may also educate program managers on other predictive 
behaviors:  smokers and high risk individuals being more likely to return, urinary 
symptoms having no obvious effect on returning participants.  For entire 
participation, urinary health symptoms are showing no significance in future 
program attendance.   
 Model 1 predicts the likely behavior that the majority of returning 
participants will consider themselves high risk, and a significant portion will smoke.  
This is possibly explained by positive relationship between those who consider 
themselves high risk and who smoke.  Note that these values don’t equal 1, but 
instead represent a proportion of the found relevant behaviors.  There may be 
several behavioral variables that influence screening attendance that may be 
unknown.  The behavior of feeling at high risk was slightly more significant and 
therefore may represent more of the population. 
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Model 1: Likely Returning Predictive Behavior 
 
 
 Model 2 displays the unlikely characteristics of a returning participant’s 
behavior.  The majority of participants who don’t return tend to feel health 
conscious, and about one-fourth are suffering from a loss of testosterone. Note that 
these values don’t equal 1, but instead represent a proportion of the found relevant 
behaviors.  There may be several behavioral variables that influence screening 
attendance that may be unknown.  The behavior of feeling at health conscious was 
substantially more significant and therefore may represent more of the population. 
Model 2: Unlikely Returning Predictive Behavior 
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African-American participant models can also be derived using similar variables that 
may have significance on future African-American attendance:   
Table 10:  Predictive Returning Participant Model African-American Men 
Variable Coefficient T-Test Value P-Value 
I consider myself health conscious -0.266 -0.670 0.509 
Urinary Health Symptoms -0.096 -0.810 0.426 
Sexual Health Symptoms -0.248 -2.780 *0.009 
Interested in overall men’s health -0.188 -0.280 0.783 
I think I am at high risk  -0.004 -0.010 0.989 
Age -0.011 -0.810 0.424 
BMI 0.041 1.460 0.153 
Testosterone Health Symptoms 0.167 2.030 *0.051 
Smoking 0.090 0.480 0.632 
My wife encouraged me to attend 0.068 0.090 0.930 
*Negative Values= Unlikely returning 
participant behavior  
              *Positive Values= Likely        
behavior for returning participants 
                                             *Variables show relevance in model  
  
Factors that predict African-American likely and unlikely returning behavior have 
similar independent variables and the dependent variable.  It is unlikely that a 
returning African-American man is attending the screening because he is 
encountering sexual health symptoms and it is likely that a returning participant is 
encountering low testosterone symptoms.  Urinary health symptoms are in fact, 
showing no relationship for returning participation in future years.  We can also infer 
from the participant model that African-Americans are just as likely to return as 
other participants, as there was no statistical significant difference.  Since prostate 
cancer is more likely for African-American men, equal participation can become a 
problem.   
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 Models 3 and 4 both show that the likely and unlikely returning African-
American participant behavior is largely unknown.  This may be reflective of the low 
number of African-American screening participants.  Model 3 predicts that returning 
African-American men are somewhat of a mystery.  However, nearly 1 in 5 are 
suffering from a loss of testosterone.  Note that these values don’t equal 1, but 
instead represent a proportion of the found relevant behaviors.  The behavior of 
suffering from testosterone health symptoms held small significance, and there may 
be untracked behavioral variables that influenced attendance. 
Model 3: Likely Returning African-American Predictive Behavior 
 
 
 Model 4 predicts that nearly 25 precent of returning African-American men 
aren’t suffering from sexual health symptoms, and a large portion of the population 
is left unknown.  Unknown behavior proves to be a difficulty in specifically increasing 
this particular minority involvement.  Note that these values don’t equal 1, but 
instead represent a proportion of the found relevant behaviors.  The behavior of 
suffering from sexual health symptoms held small significance, and there may be 
untracked behavioral variables that influenced attendance. 
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Model 4: Unlikely Returning African-American Predictive Behavior 
 
 
E.  Study Limitations 
 Screening anxiety is a strong behavioral factor that may affect participant’s 
attendance and is not assessed in the study.   Previous studies assessing anxiety as a 
component of prostate cancer have been inconclusive.  Although studies have 
shown that the screening does not seem to cause any major psychological distress in 
the majority of men, it is to be expected that a higher level of psychological distress 
has been observed in those who screen positive (Carlsoon, 2007).  The fear of a 
positive test could hinder attendance rates, and this could be a factor in the 
apparent tendency of those with worse health habits to avoid returning.    
 Other program initiatives are to teach and educate participants about 
prostate cancer and prostate health, and to recommend follow-up if needed.  The 
research failed to provide information as to whether participants are learning about 
prostate cancer health and its warning signs.  The single largest factor derived from 
reasons for participation is high risk or family history with a desire for certainty, 
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which indicates some knowledge of the medical issues.  There are other factors, and 
those attending for other reasons could be educated about prostate cancer. 
 The amendment of the survey year after year proves very difficult in 
accurately coding variables and in maintaining consistency in the program.  Some 
relevant variables to determine the program’s mission were dropped after 2006.  It 
was very helpful for the PCEC to maintain consistency in the program questionnaire 
and to code variables similarly year after year.  The survey also tracked amount of 
knowledge program participants have about prostate cancer.  At only one time did 
the study ask the question, and therefore it was thrown out due to the extremely 
limited responses.  This question should be asked on future questionnaires, as 
education is an important part of the program’s mission.  It would have been nice to 
analyze more data than that of a three year period.  Data should have been available 
from 2003-2008, but the PCEC had misplaced 2005 data.  It also would have been a 
more conclusive study to look at data from other PCEC screening sites within the 
state of Kentucky. 
 Variables that may have been significant were eliminated from analyses as 
they were incomplete.  Questionnaires failed to track variables such as the relevant 
“other” category on method of learning about the program, and the “work” variable 
wasn’t captured in 2006 at all.  I anticipate the “work” variable would have more 
significance with complete data.   
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IV.  Conclusion and Recommendations 
 Prostate Cancer Screening serves as an effective means of early detection as 
backed by numerous literature and research sources.  The data presented shows an 
effective means of generalizing participant behavior and those factors which 
influence medial attendance.  Participant models should help program managers 
understand their served populations.  The findings from the study may help program 
managers market the program more effectively and more efficiently.  
 Certain variables have more relevance in screening attendance than others.  
Variables that had some behavioral and medical significance were: smoking, diet in 
fat, BMI, urinary, testosterone and sexual health symptoms, and if the participants 
were health conscious or not.  Variables that showed significant difference between 
likely and unlikely returning participant behavior were placed into participant 
models to predict whether or not they will return.  These participant models may be 
useful to program managers in understanding screening participant behaviors and to 
help target program marketing efforts to encourage retention.   
 Participant models generally showed that returning participants believed 
they were at high risk for prostate cancer, and tended to smoke.  However, the 
program seems to discourage retention of men who are self-declared health 
conscious and who may be suffering from a loss of testosterone.   Program managers 
should work on recruiting and retaining men with these behaviors.  It is good that 
men at high risk are attracted to the program, but other groups can be targeted 
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more specifically:  those who are generally health conscious, and wives of men who 
are not!  It would be helpful for program manager’s to use participant model 
concepts to continue to predict behavior, and to apply these methods to other 
cancer screening programs. 
 It is also important for program managers to notice the decrease in 
participation for this three-year period.  As this is a grant-funded program, 
attendance is imperative to its survival.  A marketing plan should be put in place to 
increase participation in the upcoming years.  Currently, the most effective 
marketing method is word of mouth via friends and family and the use of newspaper 
ads for new participants.  There are two marketing methods that should be 
explored.  New participants can be recruited by advertising on the radio or 
television, and returning participants should be sought at places of work.   
 The internet proved to have nearly no impact, which clearly needs to be 
addressed as it has become a critical marketing tool in the 20th century.  Known for 
its ability to provide inexpensive advertising, all avenues of internet marketing are 
feasible.  Marketing via www.uky.edu/healthcare should be explored.    
 African-American participation has also decreased in this three-year period.  
Because program initiatives focus on increasing minority participation and their 
higher incidence of prostate cancer, program managers should pay special attention 
to under-utilized marketing methods.  To target the African-American population 
program specifically, managers should look at reaching out to potential places of 
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employment.  Other successful marketing mediums were also the newspapers and 
on radio and television.   
 Despite the smaller sample size available, results indicated that sexual health 
problems attracted African-Americans to the program, but proved to be an unlikely 
behavior for a returning participant.  This suggests both a means of advertising that 
might work and the need to emphasize that urinary problem symptoms are also a 
reason to participate, and in fact may be medically more relevant. 
 Although predictions for African-American men are largely unknown, these 
models do show two relevant likely and unlikely behaviors for returning men.  If 
there is a likely predictive behavior, a minority of new African-American men will be 
suffering from a loss of testosterone, and it is unlikely that returning African-
American men will be suffering from sexual health symptoms.  These two specific 
behaviors tell managers that to increase the African-American participation specific 
marketing methods should target these symptoms. 
 It appears that men in general aren’t educated on the relation of urinary 
symptoms to that of prostate cancer as explained by the National Kidney and 
Urologic Disease Information Clearinghouse.  It’s unfortunate that urinary symptoms 
played a nominal role in participation attendance.  Instead men are more likely to be 
suffering from sexual health problems, and therefore relating these symptoms to 
the potential that they may have prostate cancer.     
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VI.  Appendices:  Charts and Tables 
Chart  5:  Participant’s Diet in Fat 2006-2008 
 
        *Source:  PCEC 2008 
Chart  6:  African-American Participant’s Diet in Fat 2006-2008 
 
       *Source:  PCEC 2008 
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Chart  7:  Participant’s Incidence of Smoking 2006-2008 
 
       *Source:  PCEC 2008 
Chart  8:  Participant’s Incidence of Smoking African-American Men 2006-2008 
 
        *Source:  PCEC 2008 
 39 
 
Chart  9: Participant’s Amount of Exercise 2006-2008 
 
        *Source:  PCEC 2008 
Chart  10:  Amount of Exercise African-American Men 2006-2008 
 
         *Source:  PCEC 2008
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Chart  11:  Participant’s Health Conditions 2006-2008 
 
              *Source:  PCEC 2008 
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Chart  12: Participant’s Health Conditions African-American Men 2006-2008 
 
              *Source:  PCEC 2008
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Chart  13:  Participant’s Health History- High Risk 2006-2008  
 
  *Diabetes, Heart Disease and Lung Cancer were tracked in 2007 and 2008 only            *Source:  PCEC 2008 
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Chart  14: Health History African-American Men- High Risk 2006-2008  
 
  *Diabetes, Heart Disease and Lung Cancer were tracked in 2007 and 2008 only         *Source:  PCEC 2008 
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Chart  15:  Participant Reason Attended 2006-2008 
 
  *Source:  PCEC 2008 
Chart  16:  African-American Participant’s Reason for Attending 2006-2008 
 
         *Source:  PCEC 2008 
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Chart  17:  New Program Participants:  Reason Attended 2006-2008  
 
          *Source:  PCEC 2008 
 
 
Table 11:  Factor Analysis Pattern Matrix, Urinary Symptoms: 
Variable Factor 1 Factor 2 Factor 3 
Sensation of not emptying your bladder *0.7794 -0.104 -0.1218 
How have have you had to urinate? *0.7309 0.1731 -0.0586 
How often have you found you stopped and started? *0.7887 -0.1496 -0.0760 
How often have you found it difficult to postpone? *0.7117 0.1554 840 
How often have you had a weak urinary stream? *0.7574 -0.1483 0.0765 
How often do you push or strain to begin urination? *0.7377 -0.1501 0.1212 
How many times do you get up to urinate at night? *0.5918 0.1916 0.0644 
How would you feel about your urinary condition? *0.5902 0.1212 -0.0805 
 *Results are relevant 
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Table 12:  Factor Analysis Pattern Matrix, Sexual Health Symptoms: 
Variable Factor 1 Factor 2 Factor 3 
How do you rate your confidence that you could get 
and keep an erection? *0.6619 0.0775 0.0393 
When you had erections, how often were they hard 
enough for penetration? *0.8698 0.1186 -0.0122 
How often were you abot to maintain your erection? *0.9195 0.0476 -0.0254 
How difficult was it to maintain your erection to 
completion? *0.9132 -0.0917 0.0189 
How often was intercourse satisfactory to you? *0.8905 -0.01286 -0.0105 
 *Results are relevant 
 
 
 
 
Table 13:  Factor Analysis Pattern Matrix, Testosterone Health Symptoms: 
Variable Factor 1 Factor 2 Factor 3 
Do you have a decrease in libido? *0.8986 0.1898 0.1118 
Do you have a lack of energy? *0.9307 0.0505 -0.1439 
Do you have a decrease in strength and/or 
endurance? *0.9075 0.1444 -0.1505 
Have you lost height? *0.9186 -0.1087 0.0377 
Have you noticed a decreased "enjoyment in life"? *0.9459 -0.1734 0.0404 
Are you sad and/or grumpy? *0.9441 -0.1807 0.0522 
Are your erections less strong? *0.8414 0.2381 0.1256 
Have you noticed a recent deteroriation in your 
ability to play sports? *0.9089 0.0302 -0.0759 
Are you falling asleep after dinner? *0.9068 -0.0349 0.0271 
Have there been a recent deterioration in your work 
performance? *0.9568 -0.1153 -0.0139 
 *Results are relevant 
 
 
 
 
